Vaxabov B.M. 2025. HYPERLIPIDEMIA-SPECIFIC BIOMARKERS WOULD IMPROVE CLINICAL DIAGNOSIS AND THERAPEUTIC TREATMENT AT EARLY DISEASE STAGES. Journal of Applied Science and Social Science. 15, 12 (Dec. 2025), 627–630.